Last reviewed · How we verify
EMLA cream 5%
EMLA cream 5% is a Small molecule drug developed by HaEmek Medical Center, Israel. It is currently FDA-approved. Also known as: no other names, Standard EMLA 5% patch.
EMLA cream 5%, marketed by HaEmek Medical Center, is a topical anesthetic with a well-established presence in the market. The drug's key strength lies in its composition patent, which is set to expire in 2028, providing a period of exclusive market protection. The primary risk is the potential increase in competition following the patent expiry, which could impact revenue.
At a glance
| Generic name | EMLA cream 5% |
|---|---|
| Also known as | no other names, Standard EMLA 5% patch |
| Sponsor | HaEmek Medical Center, Israel |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Virtual Reality for Port-a-Cath Access (NA)
- Diminishing Accelerated Long-term Forgetting in Mild Cognitive Impairment (PHASE1, PHASE2)
- Variability of the Unique Fiber Potentials of a Spastic Muscle Treated With Botulinum Toxin (NA)
- Transdermal Microneedle Lignocaine Delivery Versus EMLA Patch for Topical Analgesia Before Venepuncture Procedure To Adults in Clinical Setting (PHASE1, PHASE2)
- Local Anesthesia Before Bulkamid Injection (NA)
- Laser Therapy in Women With Lichenoid Disorders (NA)
- Efficacy of Platelet-rich Plasma in Management of Anosmia (NA)
- Pharmacological and Nonpharmacological Methods for Children in Venipuncture Pain (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- EMLA cream 5% CI brief — competitive landscape report
- EMLA cream 5% updates RSS · CI watch RSS
- HaEmek Medical Center, Israel portfolio CI
Frequently asked questions about EMLA cream 5%
What is EMLA cream 5%?
Who makes EMLA cream 5%?
Is EMLA cream 5% also known as anything else?
What development phase is EMLA cream 5% in?
Related
- Manufacturer: HaEmek Medical Center, Israel — full pipeline
- Also known as: no other names, Standard EMLA 5% patch
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing